Hudan Liu


1Department of Cancer Biology, Medical Research Institute,

Frontier Science Center for Immunology and Metabolism,

2Department of Hematology, Zhongnan Hospital,

Wuhan University School of Medicine,

Wuhan, China



Hudan Liu, PhD


BS in Biochemistry 1997

Wuhan University

MS in Molecular Biology 2000

Shanghai Institute of Biochemistry and Cell Biology, Chinese Aca-demy of Sciences

PhD in Cell and Development Biology 2005

Rutgers, the State University of New Jersey, NJ, USA

Research Areas:

1. We focus on understanding molecular pathology of tumorigenesis using multiple in vitro and in vivo approaches with particular attentions on major oncogenes, NOTCHand MYC.

2. We attempt to develop novel, mechanism-based targeted or combination therapy in cancer treatment, and evaluate the efficacy and safety in pre-clinical models.

Selected Publications: (* corresponding author)

1. Jiang J, Wang J, Yue M, Cai X, Wang T, Wu C, Su H, Wang Y, Han M, Zhang Y, Zhu X, Jiang P, Li P, Sun Y, Xiao W, Feng H, Qing G, Liu H*. Direct Phosphorylation and Stabilization of MYC by Aurora B Kinase Promote T-cell Leukemogenesis. Cancer Cell. 2020, 37(2):200-215.

2. Hu J, Wang T, Xu J, Wu S, Wang L, Su H, Jiang J, Yue M, Wang J, Wang D, Li P, Zhou F, Liu Y, Qing G, Liu H*. WEE1 inhibition induces glutamine addiction in T-cell acute lymphoblastic leukemia. Haematologica. 2020, In Press. pii: haematol.2019.231126.

3. Wang J, Jiang J, Chen H, Wang L, Guo H, Yang L, Xiao D, Qing G*, Liu H*. FDA-approved drug screen identifies proteasome as a synthetic lethal target in MYC-driven neuroblastoma. Oncogene. 2019, 38(41):6737-6751.

4. Su H, Hu J, Huang L, Yang Y, Thenoz M, Kuchmiy A, Hu Y, Li P, Feng H, Zhou Y, Taghon T, Van Vlierberghe P, Qing G, Chen Z*, Liu H*.SHQ1 regulation of pre-RNA splicing is required for T-lymphoblastic leukemia cell survival.Nature Communications. 2018,9(1):4281.

5. Yue M, Jiang J, Gao P, Liu H*, Qing G*. Oncogenic MYC activates a feedforward regulatory loop promoting essential amino acid metabolism and tumorigenesis. Cell Reports.2017, 21(13): 3819-3832.

6. Wang Z, Hu Y, Xiao D, Wang J, Liu C, Xu Y, Shi X, Jiang P, Huang L, Li P,Liu H*, Qing G*. Stabilization of Notch1 by the Hsp90 Chaperon is Crucial for T Cell Leukemogenesis.Clinical Cancer Research.2017, 23(14):3834-3846.

7. Hu Y, Su H, Ye Q, Wang Z, Huang L, Wang Q, Liu S, Chen S, Zhou J, Li P, Liu H*, Qing G*. DEPTOR is a direct NOTCH1 target that promotes proliferation and survival in T-cell leukemia.Oncogene.2017, 36(8):1038-1047.

8. Ye Q, Jiang J, Zhan G, Yan W, Huang L, Hu Y, Su H, Tong Q, Yue M, Li H, Yao G*, Zhang Y*, Liu H*. Small molecule activation of NOTCH signaling inhibits acute myeloid leukemia.Scientific Reports. 2016;6:26510.

9. Ye Q, Yao G , Zhang M, Guo G, Hu Y, Jiang J, Cheng L, Li H, Qing G, Zhang Y*, Liu H*. A novel ent-kaurane diterpenoid executes anti-tumor function in colorectal cancer cells by inhibiting Wnt/b-catenin signaling. Carcinogenesis. 2015,36(3): 318-26.

10. Hu Y, Su H, Li X, Guo G, Qin R, Qing G, Liu H*. Jagged2 promotes pancreatic cancer metastasis independent of Notch signaling activation. Molecular Cancer Therapeutics. 2015, 14(1): 289-297.

Tel: 0086-27-68750205 Fax: 0086-27-68759675  Email:

Contact address: Donghu Road, No. 115, Wuchang District, Wuhan, Hubei Province, P.R. China. 430071

Copyright @ 2016 Medical Research Institute